Diagnostic and prognostic value of glypican-3 as a biomarker in the diagnosis of hepatocellular carcinoma in Egyptian patients with hepatitis C virus-related cirrhosis before and after interventional treatment
Conclusion
GPC-3 has better diagnostic performance than alfa feto protein (AFP) in differentiating HCC from other groups and giving better evaluation in response to treatment in different HCC groups in addition to a combination of GPC-3 and AFP among HCC groups (radiofrequency and transarterial chemoembolization) slightly increases the sensitivity of AFP.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cirrhosis | Egypt Health | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Statistics | Study | Tropical Medicine | Urology & Nephrology